For all the excitement around the AI boom, the IPO market has been relatively quiet in recent years. In fact, the only major ...
Renaissance IPO ETF (IPO) is rated a buy, anticipating a surge in major IPOs through 2026 to fuel renewed investor interest.
Its listing marks a milestone for the country’s broader AI industry, which has been under pressure from tightening U.S.
Startup Parabilis Medicines has raised $305 million in new funding, money that will help bring its lead drug for a variety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback